FI103889B1 - Menetelmä terapeuttisesti käyttökelpoisten pyrrolo[3,2-c]-kinoliini-karboksyylihappojohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten pyrrolo[3,2-c]-kinoliini-karboksyylihappojohdannaisten valmistamiseksiInfo
- Publication number
- FI103889B1 FI103889B1 FI933756A FI933756A FI103889B1 FI 103889 B1 FI103889 B1 FI 103889B1 FI 933756 A FI933756 A FI 933756A FI 933756 A FI933756 A FI 933756A FI 103889 B1 FI103889 B1 FI 103889B1
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- nz1z2
- alkoxy
- phenyl
- quinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Toys (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Plural Heterocyclic Compounds (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI962714A FI103277B1 (fi) | 1992-08-27 | 1996-07-01 | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo- ja tieno[3,2-c]naftyridiinijohdannaisten valmistamiseksi |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9210329 | 1992-08-27 | ||
| FR9210329A FR2695126B1 (fr) | 1992-08-27 | 1992-08-27 | Dérivés d'acide thiényl ou pyrrolyl carboxyliques, leur préparation et médicaments les contenant. |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI933756A0 FI933756A0 (fi) | 1993-08-26 |
| FI933756A FI933756A (fi) | 1994-02-28 |
| FI103889B FI103889B (fi) | 1999-10-15 |
| FI103889B1 true FI103889B1 (fi) | 1999-10-15 |
Family
ID=9433050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI933756A FI103889B1 (fi) | 1992-08-27 | 1993-08-26 | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo[3,2-c]-kinoliini-karboksyylihappojohdannaisten valmistamiseksi |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5360799A (ko) |
| EP (1) | EP0587473B1 (ko) |
| JP (1) | JPH06184145A (ko) |
| KR (1) | KR100267802B1 (ko) |
| AT (1) | ATE173258T1 (ko) |
| AU (1) | AU659027B2 (ko) |
| CA (1) | CA2104883A1 (ko) |
| DE (1) | DE69322033T2 (ko) |
| DK (1) | DK0587473T3 (ko) |
| ES (1) | ES2125315T3 (ko) |
| FI (1) | FI103889B1 (ko) |
| FR (1) | FR2695126B1 (ko) |
| GR (1) | GR3029283T3 (ko) |
| HU (1) | HU217623B (ko) |
| MX (1) | MX9305181A (ko) |
| NO (1) | NO300845B1 (ko) |
| NZ (1) | NZ248498A (ko) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040082602A1 (en) * | 2002-07-19 | 2004-04-29 | Hagen Timothy J. | Substituted thiophene carboxamide compounds for the treatment of inflammation |
| GB0522715D0 (en) | 2005-11-08 | 2005-12-14 | Helperby Therapeutics Ltd | New use |
| UA116187C2 (uk) | 2005-12-13 | 2018-02-26 | Інсайт Холдінгс Корпорейшн | ГЕТЕРОАРИЛЗАМІЩЕНІ ПІРОЛО[2,3-b]ПІРИДИНИ Й ПІРОЛО[2,3-b]ПІРИМІДИНИ ЯК ІНГІБІТОРИ ЯНУС-КІНАЗИ |
| CN101679357A (zh) * | 2007-05-09 | 2010-03-24 | 辉瑞大药厂 | 取代的杂环衍生物及其组合物和作为抗菌剂的药物用途 |
| ES2483728T3 (es) * | 2007-06-08 | 2014-08-07 | Dart Neuroscience (Cayman) Ltd | Derivados terapéuticos de pirazolonafatiridina |
| US8642597B2 (en) | 2007-08-27 | 2014-02-04 | Basf Se | Pyrazole compounds for controlling invertebrate pests |
| TWI480282B (zh) * | 2008-02-26 | 2015-04-11 | Takeda Pharmaceutical | 稠合雜環衍生物及其用途 |
| WO2010034737A1 (en) | 2008-09-24 | 2010-04-01 | Basf Se | Pyrazole compounds for controlling invertebrate pests |
| TW201100429A (en) | 2009-05-22 | 2011-01-01 | Incyte Corp | N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
| UA106078C2 (uk) | 2009-05-22 | 2014-07-25 | Інсайт Корпорейшн | 3-[4-(7H-ПІРОЛО[2,3-d]ПІРИМІДИН-4-ІЛ)-1H-ПІРАЗОЛ-1-ІЛ]ОКТАН- АБО ГЕПТАННІТРИЛ ЯК JAK-ІНГІБІТОРИ |
| ES2472918T3 (es) | 2009-07-06 | 2014-07-03 | Basf Se | Compuestos de piridazina para controlar plagas de invertebrados |
| CN102469785A (zh) | 2009-07-24 | 2012-05-23 | 巴斯夫欧洲公司 | 防治无脊椎动物害虫的吡啶衍生物 |
| WO2011028685A1 (en) | 2009-09-01 | 2011-03-10 | Incyte Corporation | Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors |
| TWI643857B (zh) | 2010-03-10 | 2018-12-11 | 英塞特公司 | 作為ｊａｋ１抑制劑之哌啶-４-基三亞甲亞胺衍生物 |
| JP5917545B2 (ja) | 2010-11-19 | 2016-05-18 | インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ | Ｊａｋ阻害剤としてのシクロブチル置換ピロロピリジンおよびピロロピリミジン誘導体 |
| AR086983A1 (es) | 2011-06-20 | 2014-02-05 | Incyte Corp | Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak |
| TW201313721A (zh) | 2011-08-18 | 2013-04-01 | Incyte Corp | 作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物 |
| UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
| US9193733B2 (en) | 2012-05-18 | 2015-11-24 | Incyte Holdings Corporation | Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors |
| CN104918945B (zh) | 2012-11-01 | 2018-01-05 | 因赛特公司 | 作为jak抑制剂的三环稠合噻吩衍生物 |
| NZ748448A (en) | 2012-11-15 | 2019-12-20 | Incyte Holdings Corp | Sustained-release dosage forms of ruxolitinib |
| TWI634121B (zh) | 2013-03-06 | 2018-09-01 | 英塞特控股公司 | 用於製備ｊａｋ抑制劑之方法及中間物 |
| KR20220103810A (ko) | 2013-08-07 | 2022-07-22 | 인사이트 코포레이션 | Jak1 억제제용 지속 방출 복용 형태 |
| CR20160553A (es) | 2014-04-30 | 2017-04-25 | Incyte Corp | Procesos para preparar un inhibidor de jak1 y nuevas formas de este |
| WO2015184305A1 (en) | 2014-05-30 | 2015-12-03 | Incyte Corporation | TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1 |
| EP3377490A1 (en) | 2015-11-16 | 2018-09-26 | Fundacion para la Investigacion Medica Aplicada | Novel compounds as inhibitors of dna methyltransferases |
| SI3773593T1 (sl) | 2018-03-30 | 2024-08-30 | Incyte Corporation | Zdravljenje hidradenitisa suppurative z zaviralci jak |
| US11833155B2 (en) | 2020-06-03 | 2023-12-05 | Incyte Corporation | Combination therapy for treatment of myeloproliferative neoplasms |
| KR20240101561A (ko) | 2021-10-14 | 2024-07-02 | 인사이트 코포레이션 | Kras의 저해제로서의 퀴놀린 화합물 |
| US11897883B1 (en) | 2023-09-01 | 2024-02-13 | King Faisal University | Pyrrolo[3,2-c][1,6]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors |
| US11891377B1 (en) | 2023-09-06 | 2024-02-06 | King Faisal University | Pyrrolo[3,2-c][2,7]naphthyridine-2-carboxylic acid compounds as CK2 inhibitors |
| US11866437B1 (en) | 2023-09-15 | 2024-01-09 | King Faisal University | 1,2-dioxo-2,3-dihydro-1H-pyrrolo[2,3-c]quinoline-7-carboxylic acid compounds as CK2 inhibitors |
| US11952378B1 (en) | 2023-12-14 | 2024-04-09 | King Faisal University | Pyrrolo[2,3-c]isoquinoline-1,2-dione compounds as CK2 inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3887570A (en) * | 1973-09-28 | 1975-06-03 | Squibb & Sons Inc | Derivatives of pyrazolo(3,4-b)thieno(2,3-d)pyridine-2-carboxylic acids |
-
1992
- 1992-08-27 FR FR9210329A patent/FR2695126B1/fr not_active Expired - Fee Related
-
1993
- 1993-08-19 US US08/109,073 patent/US5360799A/en not_active Expired - Fee Related
- 1993-08-20 AU AU44747/93A patent/AU659027B2/en not_active Ceased
- 1993-08-25 DK DK93402095T patent/DK0587473T3/da active
- 1993-08-25 EP EP93402095A patent/EP0587473B1/fr not_active Expired - Lifetime
- 1993-08-25 DE DE69322033T patent/DE69322033T2/de not_active Expired - Fee Related
- 1993-08-25 ES ES93402095T patent/ES2125315T3/es not_active Expired - Lifetime
- 1993-08-25 AT AT93402095T patent/ATE173258T1/de not_active IP Right Cessation
- 1993-08-25 NZ NZ248498A patent/NZ248498A/en unknown
- 1993-08-26 CA CA002104883A patent/CA2104883A1/fr not_active Abandoned
- 1993-08-26 MX MX9305181A patent/MX9305181A/es not_active IP Right Cessation
- 1993-08-26 JP JP5211451A patent/JPH06184145A/ja active Pending
- 1993-08-26 FI FI933756A patent/FI103889B1/fi active
- 1993-08-26 NO NO933051A patent/NO300845B1/no not_active IP Right Cessation
- 1993-08-26 HU HU9302425A patent/HU217623B/hu not_active IP Right Cessation
- 1993-08-27 KR KR1019930017022A patent/KR100267802B1/ko not_active IP Right Cessation
-
1994
- 1994-07-12 US US08/273,943 patent/US5468750A/en not_active Expired - Fee Related
-
1999
- 1999-02-03 GR GR990400363T patent/GR3029283T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT64957A (en) | 1994-03-28 |
| EP0587473B1 (fr) | 1998-11-11 |
| NO933051D0 (no) | 1993-08-26 |
| FI103889B (fi) | 1999-10-15 |
| AU4474793A (en) | 1994-03-03 |
| DE69322033D1 (de) | 1998-12-17 |
| KR940003958A (ko) | 1994-03-14 |
| AU659027B2 (en) | 1995-05-04 |
| ATE173258T1 (de) | 1998-11-15 |
| FI933756A (fi) | 1994-02-28 |
| KR100267802B1 (ko) | 2000-11-01 |
| CA2104883A1 (fr) | 1994-02-28 |
| NO933051L (no) | 1994-02-28 |
| DE69322033T2 (de) | 1999-06-17 |
| EP0587473A1 (fr) | 1994-03-16 |
| US5468750A (en) | 1995-11-21 |
| FR2695126B1 (fr) | 1994-11-10 |
| US5360799A (en) | 1994-11-01 |
| NZ248498A (en) | 1994-09-27 |
| FI933756A0 (fi) | 1993-08-26 |
| DK0587473T3 (da) | 1999-07-26 |
| NO300845B1 (no) | 1997-08-04 |
| ES2125315T3 (es) | 1999-03-01 |
| FR2695126A1 (fr) | 1994-03-04 |
| HU217623B (hu) | 2000-03-28 |
| JPH06184145A (ja) | 1994-07-05 |
| MX9305181A (es) | 1994-06-30 |
| GR3029283T3 (en) | 1999-05-28 |
| HU9302425D0 (en) | 1993-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI103889B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrrolo[3,2-c]-kinoliini-karboksyylihappojohdannaisten valmistamiseksi | |
| DK370682A (da) | Fremgangsmaade til fremstilling af carbapenemderivater | |
| IE802612L (en) | Bicyclo £2.2.1| heptane derivatives | |
| EA200000614A1 (ru) | 2,3-замещенные соединения индола в качестве ингибиторов сох-2 | |
| DK0615549T3 (da) | Fremgangsmåde til fremstilling af farmaceutisk aktive thiazolidin- eller oxazolidinforbindelser med en gærreduktase | |
| JPS5531042A (en) | 1,8-naphthylidine derivative and its salt | |
| AU4872793A (en) | New ellipticine compounds, a process for their preparation and pharmaceutical compositions containing them | |
| DK663588D0 (da) | Hidtil ukendte forbindelser | |
| DK50793A (da) | Fremgangsmaade til fremstilling af herbicide o-carboxypyridylimidazolinoner | |
| EP0555479A4 (ko) | ||
| AU557533B2 (en) | Oxadithiadiaza, dioxaselenadiaza, dioxatelluradiaza, and dioxathiadiaza-2,5-pentalene derivatives | |
| DE3270406D1 (en) | Amidines, process for their preparation, pharmaceutical compounds containing them and their use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HC | Name/ company changed in application |
Owner name: SANOFI |